-
Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight
11 Jul 2025 00:14 GMT
… landscape include Hepatocellular carcinoma (HCC), Non-small cell lung cancer (NSCLC), Gastric cancer, and potentially other … the Report
Hepatocellular carcinoma (HCC), Non-small cell lung cancer (NSCLC), Gastric cancer, and others
Key …
-
NCCN Awards Grants to Improve Care for People with Non-Small Cell Lung Cancer in Collaboration with Taiho Oncology, Inc.
09 Jul 2025 17:33 GMT
… in the treatment of NSCLC. This initiative is made … in the treatment of NSCLC with EGFR mutations including … promising new approaches for treating Non-Small Cell Lung Cancer. These grants provide the … Early-Stage Atypical EGFR-Mutant NSCLC (ADAPT-A)
“This …
-
Nomogram for Predicting Postoperative Cardiopulmonary Complications in Non-Small Cell Lung Cancer Based on Systemic Inflammatory Markers: A Retrospective Study
09 Jul 2025 13:50 GMT
… the post-operative diagnosis was non-small cell lung cancer; (3) patients with complete … in patients with resectable non-small cell lung cancer (NSCLC). The study found that … for sleeve lobectomy within non-small cell lung cancer. Thorac Cancer. 2024; …
-
Q&A: Validated AI Model Could Guide Real-World NSCLC Decisions
11 Jul 2025 00:26 GMT
… predict how patients with advanced NSCLC will respond to immunotherapy.
… predict how patients with advanced non-small cell lung cancer (NSCLC) will respond to immunotherapy, … responses in patients diagnosed with NSCLC, offering promising potential for …
-
Dr Ganti on the Importance of Molecular Testing in NSCLC
11 Jul 2025 03:27 GMT
… non–small cell lung cancer (NSCLC). He also highlighted the comprehensive … exon 20 insertion mutation–positive NSCLC, as well as for use … assay, and thus, patients with NSCLC may require additional or alternative …
-
From Trial to Practice: Integrating Amivantamab/Lazertinib in Advanced NSCLC
10 Jul 2025 14:41 GMT
Panelists discuss how real-world experience with amivantamab plus lazertinib has shown remarkable responses consistent with trial data, including effectiveness in challenging cases such as leptomeningeal disease, with manageable adverse effects when proper …
-
Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC
09 Jul 2025 20:03 GMT
… tumors of patients with non-small cell lung cancer (NSCLC) to shrink less than … revolutionary for patients with NSCLC, the authors wrote, … therapy in patients with NSCLC.1
The investigators enrolled … 30–89 years) with NSCLC who initiated treatment between …
-
Dr Spigel Covers the AIM-HIGH Trial in Early NSCLC
09 Jul 2025 16:15 GMT
… –small cell lung cancer (NSCLC).
The AIM-HIGH trial … stage IA, IB, or IIA NSCLC following surgical resection. Traditionally, … oncology in early-stage NSCLC and may pave the … chemotherapy for stage IA-IIA non-small cell lung cancer identified as high-risk …
-
Emerging Strategies for Overcoming On/Off-Target Resistance in ALK-Positive NSCLC
09 Jul 2025 12:49 GMT
Panelists discuss how resistance mechanisms in ALK-positive disease are driving development of next-generation inhibitors like NVL-655 that spare TRK to reduce neurocognitive toxicity while targeting compound resistance mutations, though the success of …
-
Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent Metastasis
11 Jul 2025 13:29 GMT
… an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 …
About
© 1995-2025